Table 4.
Cost of diabetes complications Type II in 2009
| Total direct costs (€ millions) | Direct cost per patient (€) | Components of direct costs (€ million, %) | |
|---|---|---|---|
| Macrovascular complications |
€757.74 |
€2776 |
Pharmaceuticals €263.69 (34.8%) |
| Inpatient €334.16 (44.1%) | |||
| Outpatient€159.88 (21.1%) | |||
| Microvascular complications |
€579.79 |
€1928 |
Pharmaceuticals €241.19 (41.6%) |
| Inpatient €189.59 (32.7%) | |||
| Outpatient €149 (25.7%) | |||
| Micro- and Macrovascular complications | €542.22 | €2930 | Pharmaceuticals €208.75 (38.5%) |
| Inpatient €217.97 (40.2%) | |||
| Outpatient €115.49 (21.3%) |